Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies ; volume:9 ; number:3 ; day:19 ; month:5 ; year:2018 ; pages:1317-1334 ; date:6.2018
Diabetes therapy ; 9, Heft 3 (19.5.2018), 1317-1334, 6.2018
- Classification
-
Medizin, Gesundheit
- Creator
-
Ginsberg, Henry N.
- Contributor
-
Farnier, Michel
Robinson, Jennifer G.
Cannon, Christopher P.
Sattar, Naveed
Baccara-Dinet, Marie T.
Letierce, Alexia
Bujas-Bobanovic, Maja
Louie, Michael J.
Colhoun, Helen M.
SpringerLink (Online service)
- DOI
-
10.1007/s13300-018-0439-8
- URN
-
urn:nbn:de:101:1-2018081511312285669859
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ginsberg, Henry N.
- Farnier, Michel
- Robinson, Jennifer G.
- Cannon, Christopher P.
- Sattar, Naveed
- Baccara-Dinet, Marie T.
- Letierce, Alexia
- Bujas-Bobanovic, Maja
- Louie, Michael J.
- Colhoun, Helen M.
- SpringerLink (Online service)
Other Objects (12)
Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care
Vitamin D and COVID-19 infection and mortality in UK Biobank
Appetite and its Regulation: Are there Palatable Interventions for Heart Failure?
Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence
Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease
Metabolic characterization of menopause: cross-sectional and longitudinal evidence
Accuracy of circulating adiponectin for predicting gestational diabetes: a systematic review and meta-analysis
Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Metabolic characterization of menopause: cross-sectional and longitudinal evidence
Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care
Vitamin D and COVID-19 infection and mortality in UK Biobank
Appetite and its Regulation: Are there Palatable Interventions for Heart Failure?
Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence
Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease
Metabolic characterization of menopause: cross-sectional and longitudinal evidence
Accuracy of circulating adiponectin for predicting gestational diabetes: a systematic review and meta-analysis
Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Metabolic characterization of menopause: cross-sectional and longitudinal evidence
Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care
Vitamin D and COVID-19 infection and mortality in UK Biobank
Appetite and its Regulation: Are there Palatable Interventions for Heart Failure?
Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence
Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease
Metabolic characterization of menopause: cross-sectional and longitudinal evidence
Accuracy of circulating adiponectin for predicting gestational diabetes: a systematic review and meta-analysis
Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)